In a five-year, double-blind study of 12,000 patients, those taking Belviq were more likely to be diagnosed with cancer than those taking a placebo (sugar pill). The FDA stated, “A range of cancer types was reported, with several different types of cancers occurring more frequently in the lorcaserin group,” including:
- Pancreatic cancer
- Colorectal cancer
- Lung cancer
This is a drug that probably should never have been on the market, and the manufacturers need to be held accountable. Those suffering from a cancer caused by Belviq deserve compensation.